Cocoa polyphenols treatment ameliorates visceral obesity by reduction lipogenesis and promoting fatty acid oxidation genes in obese rats through interfering with AMPK pathway. Issue 4 (20th July 2015)

• Record Type: Journal Article
• Authors: Ali, Faisal; Ismail, Amin; Esa, Norhaizan Mohd; Pei, Chong
• Is Part Of: European journal of lipid science and technology. Volume 118:Issue 4(2016)
• Page Start: 564
• Page End: 575
• Publication Date: 2015-07-20
• Subjects: AMPK pathway -- Cocoa polyphenols -- Fatty acid β‐oxidation genes -- Lipogenesis genes -- Visceral obesity; Oils and fats, Edible -- Periodicals; Lipids -- Periodicals; 660.63
• DOI: 10.1002/ejlt.201400581
• Languages: English
• ISSNs: 1438-7697

Abstract

Abstract : This study was conducted to investigate the pharmacological activity of cocoa polyphenols (CPs) on visceral obesity markers and the possible mechanisms. In this study, Sprague–Dawley (SD) rats were fed either a low‐fat diet (LFD) or a high‐fat diet (HFD). After 12 wk of diet intervention, only one group of HFD rats ( n = 10/group) were treated at a dose of 600 mg/kg bw/day CPs (HFD + CPs) for 4 wk. The gene and protein expression levels of phosphorylation of AMPK‐activated protein kinase α/β (AMPK α/β) were measured using real time‐PCR and Western blotting. The mRNA expression of lipogenic key enzymes (Acaca, Fasn, Mcat, and Scd‐1), and β‐oxidation key enzymes (CPT1, Prkaa1, Acox1) were investigated. In addition, the upstream transcription factors (PPARα, PPARγ, C/EBPα, and SREBP‐1c) were also examined. In accordance with these findings, CPs treatment improved visceral adiposity, adipocytes hypertrophy, and liver steatosis. AMP‐activated protein kinase α/β (AMPK α/β) phosphorylation in liver and adipose tissue of HFD + CPs‐treated rats was activated compared with HFD‐fed rats. The expression of lipogensis related‐genes was decreased, while expression levels of β‐oxidation‐related genes were increased compared with HFD‐fed rats. Together, these data partially unravel the ameliorative effects of CPs treatment on visceral obesity markers by inhibiting lipogenesis and promoting β‐oxidation related‐genes through activation of the AMPK pathway. Practical applications: There is a metabolic logic linking the expended visceral or abdominal fat depot to dyslipidemia. The conceivability of using a natural dietary supplement to regulate lipid metabolism homeostasis is appealing as this by product of the defatted cocoa juice industry is non‐toxic, cheap, and has shown hypolipidemic properties. This is essentially significant in the context of the rising costs of obesity and its related diseases care. The ability of polyphenolics to suppress SREBP‐1c, the target of statins, while activating PPARα, the target of fibrates, suggest it can naturally find its role in the treatment of hyperlipidemia. The molecular mechanism underlying the therapeutic actions of polyphenolics ‐derived cocoa against visceral obesity has been partially unveiled in this research. Our findings suggest that CPs treatment attenuated diet‐induced visceral obesity via transcriptional regulation of AMPK mediating lipid metabolism‐related genes in the liver and visceral white adipose tissue. Abstract : The molecular mechanism underlying the therapeutic actions of polyphenolics ‐derived cocoa against visceral obesity has been partially unveiled in this research. Our findings suggest that CPs treatment attenuated diet‐induced visceral obesity via transcriptional regulation of AMPK mediating lipid metabolism‐related genes in the liver and visceral white adipose tissue.